Nxera Pharma launches J-ESOP for Japanese employees, replacing RSU plan

Nxera Pharma Co. Ltd announced on November 19, 2025, that its board of directors has approved the replacement of the existing Restricted Share Unit (RSU) Plan with a new Employee Stock Ownership Plan (J-ESOP) for employees residing in Japan. This new trust-based scheme, modeled after the US ESOP, aims to provide employees with tax benefits and mitigate concentrated share sales often seen under RSU Plans by granting shares or cash equivalents based on points accumulated upon retirement. Mizuho Trust & Banking Co., Ltd. will act as the trustee.

The J-ESOP will involve Nxera Pharma entrusting funds to Mizuho Trust & Banking for the acquisition of company shares, either through market transactions or new share issuance. Employees will be awarded points according to established Share Benefit Rules and will receive company shares or cash equivalents upon meeting beneficiary requirements. This change is specifically for Japanese employees; the RSU Plan for executives and employees not residing in Japan remains unchanged. The number of shares to be issued by the company will not change as a result of this introduction.

Nxera Pharma, a technology-powered biopharma company, has approximately 400 global employees. The company states this new plan will further increase employee motivation and engagement by aligning their interests with share price and performance improvements, contributing to increased corporate value.